Revance Therapeutics, Inc. Note Agreements

1 Contracts & Agreements

Recent Contracts

Note Purchase Agreement dated March 18, 2022 among Revance Therapeutics, Inc., certain subsidiaries of Revance Therapeutics, Inc., Athyrium Buffalo LP and the purchasers from time... (Filed With SEC on May 10, 2022)